Skip to main content

Soihtu DTx

The startup develops a digital therapy platform that utilizes an immersive video game to treat major depressive episodes, particularly for patients who do not respond to traditional therapies. This approach aims to achieve measurable reductions in depressive symptoms and improvements in quality of life, with outcomes comparable to psychotherapy.

Traction 4/10
HQ unknown
Founded 202311100+ followers
  • Content & Publishing
  • Digital Health
  • Gaming & eSports
  • Software Only
Updated 6 months ago

Funding

Raised to date

$120KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Jukka Laakso

CEO / Games / DTx / Entrepreneurship / Leadership

Product

Problem

Many individuals struggling with major depressive disorder do not respond adequately to traditional treatments like medication and psychotherapy. Stigma, limited availability, and long waiting times create further barriers to accessing effective mental healthcare.

Solution

Soihtu DTx offers a digital therapeutic platform that uses engaging, narrative-driven video games to treat major depressive episodes. The platform delivers personalized interventions tailored to individual needs, complementing existing treatments and providing a scalable solution for mental healthcare. By combining scientific research with the engaging power of gameplay, Soihtu DTx aims to make evidence-based mental healthcare more accessible and effective. The game-based approach empowers patients to actively participate in their recovery, driving meaningful improvements in their lives.

Target Audience

The primary target audience includes individuals with major depressive disorder who have not found sufficient relief from traditional treatments, as well as mental health professionals seeking innovative and scalable therapeutic tools.

Features

  • Narrative-driven gameplay designed to be engaging and impactful for patients with depression
  • Personalized treatment pathways using precision psychiatry to optimize individual outcomes
  • Clinically validated in large-scale trials for effectiveness and safety
  • Seamless integration with existing treatment modalities
  • Novel method (CORTO) for measuring digital intervention user experience
This profile is AI-generated and may contain inaccuracies.